Mark Westgate Net Worth

Mark Westgate biography

Mark Westgate CPA serves as Independent Director of the Company. Mr. Westgate joined our Board in May 2017. Mr. Westgate is currently the Vice President of Finance & Accounting for Boston Biomedical, Inc., a wholly owned subsidiary of Sumitomo Dainippon Pharma. From 2011 to October 2018 he was the Chief Financial Officer of Hitachi Chemical Advanced Therapeutics Solutions, LLC (formerly PCT Cell Therapy Services, LLC). From 2002 to 2011, he was Chief Financial Officer, Treasurer and Assistant Secretary for Apricus Biosciences, Inc. (formerly NexMed, Inc.), a drug development company (NASDAQ: APRI). From 1998-2002, Mr. Westgate was group Controller and Treasurer of Lavipharm Corp., an international pharmaceutical research and development company. He received his Bachelor of Business Administration in Public Accounting from Pace University. Mr. Westgate is a Certified Public Accountant in the state of New York. Westgate will be a valuable asset to the Company and its Board by providing substantial insight to the Board, particularly in connection with finance and accounting matters. Mr. Westgate is one of our independent directors pursuant to applicable NASDAQ rules and is qualified as an Audit Committee Financial Expert as defined in Regulation S-K Item 407(d)(5)(ii).

How old is Mark Westgate?

Mark Westgate is 50, he's been the Independent Director of ThermoGenesis Inc since 2017. There are 5 older and 4 younger executives at ThermoGenesis Inc. The oldest executive at ThermoGenesis Holdings Inc is Philip H. Coelho, 77, who is the Chief Technology Officer.

What's Mark Westgate's mailing address?

Mark's mailing address filed with the SEC is 2711, Citrus Road, Rancho Cordova, Sacramento County, California, 95742, United States of America.

Insiders trading at ThermoGenesis Inc

Over the last 5 years, insiders at ThermoGenesis Inc have traded over $612,000 worth of ThermoGenesis Inc stock. The most active insiders traders include Xiaochun Boyalife Group, In... and Thomis Joseph. On average, ThermoGenesis Inc executives and independent directors trade stock every 0 days with the average trade being worth of $120,000. The most recent stock trade was executed by Xiaochun Boyalife Group, In... on 17 November 2023, trading 600,000 units of THMO stock currently worth $612,000.

What does ThermoGenesis Inc do?

thermogenesis holdings, inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (car)-t and other cell-based therapies. it markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed car-txpress platform, which streamlines the manufacturing process for the emerging car-t immunotherapy market. the company operates through two segments, device and clinical development. it manufactures and markets products for clinical bio-banking applications, including axp automated cell separation system, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and bioarchive automated cryopreservation system, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical appli

ThermoGenesis Inc executives and stock owners

ThermoGenesis Inc executives and other stock owners filed with the SEC include:

• Dr. Xiaochun Xu M.B.A., Ph.D.,
  Chairman & CEO
• Xiaochun Xu,
  Chairman of the Board, President, Chief Executive Officer
• Jeffery Cauble CPA,
  CFO, Principal Financial & Accounting Officer and Corp. Sec.
• Jeff Cauble,
  CFO, Principal Financial & Accounting Officer and Sec.
• Jeffery Cauble,
  Chief Financial Officer, Corporate Secretary
• Mark Westgate,
  Independent Director
• Joseph Thomis,
  Independent Director
• Russell Medford,
  Independent Director
• Debra Donaghy,
  Independent Director
• Philip H. Coelho,
  Chief Technology Officer
• Mindy Wilke-Douglas,
  VP of Operations
• Haihong Zhu,
  Chief Operating Officer
• Xiaochun Boyalife Asset Hol...,
  CEO
• Xiaochun Boyalife Group, In...,
  CEO
• Xiaochun Boyalife Group, In...,
  CEO